Cell-free RNA signatures predict Alzheimer’s disease
Summary: There is a need for affordable, scalable, and specific blood-based biomarkers for Alzheimer’s disease that can be applied to a population level. We have developed and validated disease-specific cell-free transcriptomic blood-based biomarkers composed by a scalable number of transcripts that...
Main Authors: | Alejandro Cisterna-García, Aleksandra Beric, Muhammad Ali, Jose Adrian Pardo, Hsiang-Han Chen, Maria Victoria Fernandez, Joanne Norton, Jen Gentsch, Kristy Bergmann, John Budde, Joel S. Perlmutter, John C. Morris, Carlos Cruchaga, Juan A. Botia, Laura Ibanez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223026111 |
Similar Items
-
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways
by: Lihua Wang, et al.
Published: (2023-04-01) -
Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
by: Elena Chipi, et al.
Published: (2019-08-01) -
Wiley encyclopedia of chemical biology (4 vols.)
by: John Wiley & Sons
Published: (2009) -
Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease
by: Maria V. Fernández, et al.
Published: (2018-04-01) -
Medical biochemistry /
by: 394575 Baynes, John W., et al.
Published: (2009)